Vaccination of 50+ adults to promote healthy ageing in Europe: The way forward

WAidid-EVASG Panel on vaccination of 50+

Research output: Contribution to journalReview articlepeer-review


The proportion of the population ≥65 years old is about 17% today and will be about 27% in 2050 worldwide. The problem, however, is not ageing in itself, it is individual disabilities associated with ageing. This manuscript summarizes the consensus points reached during a pan-European meeting on gaps and barriers in making vaccination of adults aged 50+ a reality and on further joint actions in Europe. The shift from childhood to life-long vaccination is essential to prevent disability, morbidity and mortality in the elderly and promote healthy ageing. This vaccination shift is a major challenge in the post-truth, media-based era in countries with dwindling resources for the provision of healthcare. The challenge can be met only by adopting an innovative approach designed to shift the mindset of decision-makers from treatment to prevention. A number of key actions are required and for these actions a European multidisciplinary network including health authorities, medical doctors with different specialties, sociologists, psychologists, pharmaceutical companies and Associations of patients appears mandatory.

Original languageEnglish
Pages (from-to)5819-5824
Number of pages6
Issue number39
Publication statusPublished - Sep 18 2018


  • Aged
  • Communicable Disease Control
  • Communicable Diseases/epidemiology
  • Congresses as Topic
  • Decision Making
  • Europe
  • Health Resources
  • Healthy Aging
  • Humans
  • Middle Aged
  • Preventive Health Services/trends
  • Vaccination/statistics & numerical data


Dive into the research topics of 'Vaccination of 50+ adults to promote healthy ageing in Europe: The way forward'. Together they form a unique fingerprint.

Cite this